Modeling Combinatorial Cancer Therapy to Improve Oncolytic Adenovirus Efficacy
Author Information
Author(s): Bagheri Neda, Shiina Marisa, Lauffenburger Douglas A., Korn W. Michael
Primary Institution: Massachusetts Institute of Technology
Hypothesis
Can a dynamical systems model predict the impact of MEK inhibition on tumor cell proliferation and oncolytic adenovirus efficacy?
Conclusion
The study concludes that integrated computational and experimental analysis can identify effective treatment protocols that enhance oncolytic therapy for cancer.
Supporting Evidence
- Simulations predicted enhanced combinatorial therapy when both treatments were applied simultaneously.
- MEK inhibition up-regulated CAR expression, improving adenovirus entry into cancer cells.
- Cell cycle arrest due to MEK inhibition was shown to affect virus replication and cell death.
Takeaway
This study uses math to figure out how to make a cancer virus work better by using a special drug that helps the virus get into cancer cells.
Methodology
The researchers developed a nonlinear differential equation model to simulate the effects of MEK inhibition and oncolytic adenovirus infection on cancer cell dynamics.
Limitations
The model does not fully capture the physiological complexities of human tumors and assumes uniformity in cancer cell populations.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website